Investigating the effect of organosulfur compounds on children's lung infections

Phase 3

Recruiting

• Conditions: Pneumonia.; Bronchopneumonia, unspecified organism; J18.0

• Registration Number: IRCT20221129056657N2
• Lead Sponsor: Hossein Niktale - the inventor of medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 March 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Patient age 3 to 16 years
The patient does not need a ventilator
A patient with pneumonia and hospitalized in the special care, infectious and lung department

Exclusion Criteria

History of allergy to allicin-L-cysteine
History of allergy to garlic and onion
Patients with a history of hypotension or gastrointestinal bleeding
Low blood pressure of the patient at the beginning of the study (below 120/80)
Immune compromised patients - under chemotherapy, organ and bone marrow transplantation, and patients with autoimmune diseases
The patient's inability to swallow oral medication that is not embedded in the NGtube or other delivery method.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fever. Timepoint: The first day of the study before the start of the intervention and the seventh day of the study (the last day of the intervention). Method of measurement: Digital thermometer.;Blood oxygen (SpO2). Timepoint: The first day of the study before the start of the intervention and the seventh day of the study (the last day of the intervention). Method of measurement: Pulse Oximeter.;Erythrocyte Sedimentation Rate (ESR). Timepoint: The first day of the study before the start of the intervention and the seventh day of the study (the last day of the intervention). Method of measurement: Westergren method.